Intracranial Therapeutic Delivery Market

Market Study on Intracranial Therapeutic Delivery: Industry Benefiting from Rising Neurological Disorder Prevalence and Tangible Shift toward Regenerative Medicines

Intracranial Therapeutic Delivery Market Segmented By Cell-based Therapy, Gene Therapy, Enzyme Replacement Therapy with Spinal Muscular Atrophy, Multiple Sclerosis, Batten Disease, Amyotrophic Lateral Sclerosis Indication

  • August-2022
  • PMRREP33142
  • 168 Pages
  • Healthcare
  • PPT, PDF, WORD, EXCEL

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

    2.3. Inclusions / Exclusions

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Product Innovation / Development Trends

4. Key Success Factors

    4.1. Disease Epidemiology

    4.2. Key Promotional Strategies, By Manufacturers

    4.3. Porter’s Analysis

    4.4. PESTLE Analysis

    4.5. Value Chain

5. Market Background

    5.1. Macro-Economic Factors

        5.1.1. Global GDP Growth Outlook

        5.1.2. Global Healthcare Expenditure

    5.2. Forecast Factors - Relevance & Impact

        5.2.1. Top Companies Historical Growth

        5.2.2. GDP Growth forecast

        5.2.3. Strategic Collaborations among Players

        5.2.4. Rising Number of Pipeline Products for Gene-Based Therapies

        5.2.5. Growing prevalence of Neurologic Diseases

        5.2.6. Entries of new start-up companies in the market

    5.3. Market Dynamics

        5.3.1. Drivers

        5.3.2. Restraints

        5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

    6.1. 2021 Market Scenario

    6.2. COVID-19 and Impact Analysis

        6.2.1. Revenue by Therapy

        6.2.2. Revenue by Indication

        6.2.3. Revenue by Country

7. Global Intracranial Therapeutic Delivery Market Demand (in Value or Size (US$ Mn) Analysis 2017-2021 and Forecast, 2022–2032

    7.1. Historical Market Value (US$ Mn) Analysis, 2017–2021

    7.2. Current and Future Market Value (US$ Mn) Projections, 2022–2032

        7.2.1. Y-o-Y Growth Trend Analysis

        7.2.2. Absolute $ Opportunity Analysis

8. Global Intracranial Therapeutic Delivery Market Analysis 2017-2021 and Forecast 2022–2032, By Therapy

    8.1. Introduction / Key Findings

    8.2. Historical Market Size (US$ Mn) Trend Analysis By Therapy, 2017–2021

    8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Therapy, 2022–2032

        8.3.1. Cell-Based Therapy

        8.3.2. Gene Therapy

        8.3.3. Enzyme Replacement Therapy

    8.4. Market Attractiveness Analysis By Therapy

9. Global Intracranial Therapeutic Delivery Market Analysis 2017-2021 and Forecast 2022–2032, by Indication

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ Mn) Trend Analysis By Indication, 2017–2021

    9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Indication, 2022–2032

        9.3.1. Spinal Muscular Atrophy (SMA)

        9.3.2. Multiple Sclerosis

        9.3.3. Batten Disease

        9.3.4. Amyotrophic lateral sclerosis

    9.4. Market Attractiveness Analysis By Indication

10. Global Intracranial Therapeutic Delivery Market Analysis 2017-2021 and Forecast 2022–2032, by Region

    10.1. Introduction

    10.2. Historical Market Size (US$ Mn) Trend Analysis, By Region, 2017-2021

    10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2022–2032

        10.3.1. U.S.

        10.3.2. Europe

        10.3.3. Rest of the World (ROW)

    10.4. Market Attractiveness Analysis By Region

11. U.S Intracranial Therapeutic Delivery Market Analysis 2017-2021 and Forecast 2022–2032

    11.1. Introduction

    11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021

    11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022–2032

        11.3.1. By Therapy

        11.3.2. By Indication

    11.4. Market Attractiveness Analysis

        11.4.1. By Therapy

        11.4.2. By Indication

    11.5. Key Market Participants - Intensity Mapping

    11.6. Drivers and Restraints - Impact Analysis

12. Europe Intracranial Therapeutic Delivery Market Analysis 2017-2021 and Forecast 2022–2032

    12.1. Introduction

    12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021

    12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022–2032

        12.3.1. By Country

            12.3.1.1. Germany

            12.3.1.2. Italy

            12.3.1.3. France

            12.3.1.4. U.K.

            12.3.1.5. Spain

            12.3.1.6. BENELUX

            12.3.1.7. Nordic Countries

            12.3.1.8. Russia

            12.3.1.9. Rest of Europe

        12.3.2. By Therapy

        12.3.3. By Indication

    12.4. Market Attractiveness Analysis

        12.4.1. By Country

        12.4.2. By Therapy

        12.4.3. By Indication

    12.5. Key Market Participants - Intensity Mapping

    12.6. Drivers and Restraints - Impact Analysis

    12.7. Country Level Analysis & Forecast

        12.7.1. Germany Intracranial Therapeutic Delivery Market

            12.7.1.1. Introduction

            12.7.1.2. Market Analysis and Forecast by Market Taxonomy

                12.7.1.2.1. By Therapy

                12.7.1.2.2. By Indication

        12.7.2. France Intracranial Therapeutic Delivery Market

            12.7.2.1. Introduction

            12.7.2.2. Market Analysis and Forecast by Market Taxonomy

                12.7.2.2.1. By Therapy

                12.7.2.2.2. By Indication

        12.7.3. Italy Intracranial Therapeutic Delivery Market

            12.7.3.1. Introduction

            12.7.3.2. Market Analysis and Forecast by Market Taxonomy

                12.7.3.2.1. By Therapy

                12.7.3.2.2. By Indication

        12.7.4. Spain Intracranial Therapeutic Delivery Market

            12.7.4.1. Introduction

            12.7.4.2. Market Analysis and Forecast by Market Taxonomy

                12.7.4.2.1. By Therapy

                12.7.4.2.2. By Indication

        12.7.5. U.K. Intracranial Therapeutic Delivery Market

            12.7.5.1. Introduction

            12.7.5.2. Market Analysis and Forecast by Market Taxonomy

                12.7.5.2.1. By Therapy

                12.7.5.2.2. By Indication

        12.7.6. Benelux Union Intracranial Therapeutic Delivery Market

            12.7.6.1. Introduction

            12.7.6.2. Market Analysis and Forecast by Market Taxonomy

                12.7.6.2.1. By Therapy

                12.7.6.2.2. By Indication

        12.7.7. Nordic Countries Intracranial Therapeutic Delivery Market

            12.7.7.1. Introduction

            12.7.7.2. Market Analysis and Forecast by Market Taxonomy

                12.7.7.2.1. By Therapy

                12.7.7.2.2. By Indication

        12.7.8. Russia Intracranial Therapeutic Delivery Market

            12.7.8.1. Introduction

            12.7.8.2. Market Analysis and Forecast by Market Taxonomy

                12.7.8.2.1. By Therapy

                12.7.8.2.2. By Indication

13. Rest of the World (ROW) Intracranial Therapeutic Delivery Market Analysis 2017-2021 and Forecast 2022–2032

    13.1. Introduction

    13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021

    13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022–2032

        13.3.1. By Therapy

        13.3.2. By Indication

    13.4. Market Attractiveness Analysis

        13.4.1. By Therapy

        13.4.2. By Indication

    13.5. Key Market Participants - Intensity Mapping

    13.6. Drivers and Restraints - Impact Analysis

14. Market Structure Analysis

    14.1. Market Analysis by Tier of Companies

    14.2. Market Share Analysis of Top Players

    14.3. Market Presence Analysis

        14.3.1. By Regional footprint of Players

        14.3.2. Product footprint by Players

        14.3.3. Channel Foot Print by Players

15. Competition Analysis

    15.1. Competition Dashboard

    15.2. Competition Benchmarking

    15.3. Competition Deep Dive [Tentative list]

        15.3.1. Novartis AG

            15.3.1.1. Overview

            15.3.1.2. Product Portfolio

            15.3.1.3. Key Financials

            15.3.1.4. SWOT Analysis

            15.3.1.5. Sales Footprint

            15.3.1.6. Strategy Overview

            15.3.1.7. Key Developments

        15.3.2. BioMarin

            15.3.2.1. Overview

            15.3.2.2. Product Portfolio

            15.3.2.3. Key Financials

            15.3.2.4. SWOT Analysis

            15.3.2.5. Sales Footprint

            15.3.2.6. Strategy Overview

            15.3.2.7. Key Developments

        15.3.3. CORESTEM Inc.

            15.3.3.1. Overview

            15.3.3.2. Product Portfolio

            15.3.3.3. Key Financials

            15.3.3.4. SWOT Analysis

            15.3.3.5. Sales Footprint

            15.3.3.6. Strategy Overview

            15.3.3.7. Key Developments

        15.3.4. Alaunos Therapeutics, Inc.

            15.3.4.1. Overview

            15.3.4.2. Product Portfolio

            15.3.4.3. Key Financials

            15.3.4.4. SWOT Analysis

            15.3.4.5. Sales Footprint

            15.3.4.6. Strategy Overview

            15.3.4.7. Key Developments

        15.3.5. Apic Bio

            15.3.5.1. Overview

            15.3.5.2. Product Portfolio

            15.3.5.3. Key Financials

            15.3.5.4. SWOT Analysis

            15.3.5.5. Sales Footprint

            15.3.5.6. Strategy Overview

            15.3.5.7. Key Developments

        15.3.6. Stemedica Cell Technologies, Inc.

            15.3.6.1. Overview

            15.3.6.2. Product Portfolio

            15.3.6.3. Key Financials

            15.3.6.4. SWOT Analysis

            15.3.6.5. Sales Footprint

            15.3.6.6. Strategy Overview

            15.3.6.7. Key Developments

        15.3.7. Voyager Therapeutics

            15.3.7.1. Overview

            15.3.7.2. Product Portfolio

            15.3.7.3. Key Financials

            15.3.7.4. SWOT Analysis

            15.3.7.5. Sales Footprint

            15.3.7.6. Strategy Overview

            15.3.7.7. Key Developments

        15.3.8. Bayer AG

            15.3.8.1. Overview

            15.3.8.2. Product Portfolio

            15.3.8.3. Key Financials

            15.3.8.4. SWOT Analysis

            15.3.8.5. Sales Footprint

            15.3.8.6. Strategy Overview

            15.3.8.7. Key Developments

        15.3.9. Abeona Therapeutics

            15.3.9.1. Overview

            15.3.9.2. Product Portfolio

            15.3.9.3. Key Financials

            15.3.9.4. SWOT Analysis

            15.3.9.5. Sales Footprint

            15.3.9.6. Strategy Overview

            15.3.9.7. Key Developments

        15.3.10. Spark Therapeutics

            15.3.10.1. Overview

            15.3.10.2. Product Portfolio

            15.3.10.3. Key Financials

            15.3.10.4. SWOT Analysis

            15.3.10.5. Sales Footprint

            15.3.10.6. Strategy Overview

            15.3.10.7. Key Developments

16. Assumptions and Acronyms Used

17. Research Methodology

Find Out More about the Report Coverage

List of Tables

Table 01: U.S. & Europe Intracranial Therapeutic Delivery Market Size (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, By Therapy

Table 02: U.S. & Europe Intracranial Therapeutic Delivery Market Size (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, By Indication

Table 03: U.S. & Europe Intracranial Therapeutic Delivery Market Size (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, By Region

Table 04: U.S. Intracranial Therapeutic Delivery Market Size (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, By Therapy

Table 05: U.S. Intracranial Therapeutic Delivery Market Size (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, By Indication

Table 06: Europe Intracranial Therapeutic Delivery Market Size (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, By Therapy

Table 07: Europe Intracranial Therapeutic Delivery Market Size (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, By Indication

Table 08: Europe Intracranial Therapeutic Delivery Market Size (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, By Country

Table 09: Rest of the world (ROW) Intracranial Therapeutic Delivery Market Size (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, By Therapy

Table 10: Rest of the world (ROW) Intracranial Therapeutic Delivery Market Size (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, By Indication

Explore Persistence Market Research’s expertise in promulgation of the business !

List of Chart

Figure 01: Global Intracranial Therapeutic Delivery Market Value Analysis (US$ Mn), 2017–2021

Figure 02: Global Intracranial Therapeutic Delivery Market Value Forecast (US$ Mn), 2022–2032

Figure 03: Global Intracranial Therapeutic Delivery Market Absolute $ Opportunity, 2022–2032

Figure 04: Global Intracranial Therapeutic Delivery Market Share Analysis (%), By Therapy, 2022 & 2032

Figure 05: Global Intracranial Therapeutic Delivery Market Attractiveness Analysis By Therapy, 2022–2032

Figure 06: Global Intracranial Therapeutic Delivery Market Share Analysis (%), By Indication, 2022 & 2032

Figure 07: Global Intracranial Therapeutic Delivery Market Attractiveness Analysis By Indication, 2022–2032

Figure 08: Global Intracranial Therapeutic Delivery Market Share Analysis (%), By Region, 2022 & 2032

Figure 09: U.S. Intracranial Therapeutic Delivery Market Share By Therapy 2022 (E)

Figure 10: U.S. Intracranial Therapeutic Delivery Market Share By Indication 2022 (E)

Figure 11: U.S Intracranial Therapeutic Delivery Market Size (US$ Mn) Analysis, 2022E & 2032F

Figure 12: U.S Intracranial Therapeutic Delivery Market Size (US$ Mn) Analysis, 2022E & 2032F

Figure 13: U.S. Intracranial Therapeutic Delivery Market Value Analysis (US$ Mn), 2017–2021

Figure 14: U.S. Intracranial Therapeutic Delivery Market Value Forecast (US$ Mn), 2022–2032

Figure 15: U.S. Intracranial Therapeutic Delivery Market Attractiveness Analysis By Therapy, 2022–2032

Figure 16: U.S. Intracranial Therapeutic Delivery Market Attractiveness Analysis By Indication, 2022–2032

Figure 17: Europe Intracranial Therapeutic Delivery Market Size (US$ Mn) Analysis, 2022E & 2032F

Figure 18: Europe Intracranial Therapeutic Delivery Market Size (US$ Mn) Analysis, 2022E & 2032F

Figure 19: Europe Intracranial Therapeutic Delivery Market Share By Therapy 2022 (E)

Figure 20: Europe Intracranial Therapeutic Delivery Market Share By Indication 2022 (E)

Figure 21: Europe Intracranial Therapeutic Delivery Market Share By Country 2022 (E)

Figure 22: Europe Intracranial Therapeutic Delivery Market Value Analysis (US$ Mn), 2017–2021

Figure 23: Europe Intracranial Therapeutic Delivery Market Value Forecast (US$ Mn), 2022–2032

Figure 24: Europe Intracranial Therapeutic Delivery Market Attractiveness Analysis By Therapy, 2022–2032

Figure 25: Europe Intracranial Therapeutic Delivery Market Attractiveness Analysis By Indication, 2022–2032

Figure 26: Europe Intracranial Therapeutic Delivery Market Attractiveness Analysis By Country, 2022–2032

Figure 27: Germany Market Value Proportion Analysis, 2021

Figure 28: Germany Intracranial Therapeutic Delivery Market Share Analysis(%) By Therapy, 2021 & 2032

Figure 29: Germany Intracranial Therapeutic Delivery Market Share Analysis (%) By Indication, 2021 & 2032

Figure 30: Italy Market Value Proportion Analysis, 2021

Figure 31: Italy Intracranial Therapeutic Delivery Market Share Analysis(%) By Therapy, 2021 & 2032

Figure 32: Italy Intracranial Therapeutic Delivery Market Share Analysis (%) By Indication, 2021 & 2032

Figure 33: Spain Market Value Proportion Analysis, 2021

Figure 34: Spain Intracranial Therapeutic Delivery Market Share Analysis(%) By Therapy, 2021 & 2032

Figure 35: Spain Intracranial Therapeutic Delivery Market Share Analysis (%) By Indication, 2021 & 2032

Figure 36: France Market Value Proportion Analysis, 2021

Figure 37: France Intracranial Therapeutic Delivery Market Share Analysis(%) By Therapy, 2021 & 2032

Figure 38: France Intracranial Therapeutic Delivery Market Share Analysis (%) By Indication, 2021 & 2032

Figure 39: U.K. Market Value Proportion Analysis, 2021

Figure 40: U.K. Intracranial Therapeutic Delivery Market Share Analysis(%) By Therapy, 2021 & 2032

Figure 41: U.K. Intracranial Therapeutic Delivery Market Share Analysis (%) By Indication, 2021 & 2032

Figure 42: BENELUX Market Value Proportion Analysis, 2021

Figure 43: BENELUX Intracranial Therapeutic Delivery Market Share Analysis(%) By Therapy, 2021 & 2032

Figure 44: BENELUX Intracranial Therapeutic Delivery Market Share Analysis (%) By Indication, 2021 & 2032

Figure 45: Nordic Countries Market Value Proportion Analysis, 2021

Figure 46: Nordic Countries Intracranial Therapeutic Delivery Market Share Analysis(%) By Therapy, 2021 & 2032

Figure 47: Nordic Countries Intracranial Therapeutic Delivery Market Share Analysis (%) By Indication, 2021 & 2032

Figure 48: Russia Market Value Proportion Analysis, 2021

Figure 49: Russia Intracranial Therapeutic Delivery Market Share Analysis(%) By Therapy, 2021 & 2032

Figure 50: Russia Intracranial Therapeutic Delivery Market Share Analysis (%) By Indication, 2021 & 2032

Figure 51: Rest of the world (ROW) Intracranial Therapeutic Delivery Market Size (US$ Mn) Analysis, 2022E & 2032F

Figure 52: Rest of the world (ROW) Intracranial Therapeutic Delivery Market Size (US$ Mn) Analysis, 2022E & 2032F

Figure 53: Rest of the world (ROW) Intracranial Therapeutic Delivery Market Share By Therapy 2022 (E)

Figure 54: Rest of the world (ROW) Intracranial Therapeutic Delivery Market Share By Indication 2022 (E)

Figure 55: Rest of the world (ROW) Intracranial Therapeutic Delivery Market Value Analysis (US$ Mn), 2017–2021

Figure 56: Rest of the world (ROW) Intracranial Therapeutic Delivery Market Value Forecast (US$ Mn), 2022–2032

Figure 57: Rest of the world (ROW) Intracranial Therapeutic Delivery Market Attractiveness Analysis By Therapy, 2022–2032

Figure 58: Rest of the world (ROW) Intracranial Therapeutic Delivery Market Attractiveness Analysis By Indication, 2022–2032

Customize this Report

Explore Intelligence Tailored to Your Business Goals.

Description

Intracranial Therapeutic Delivery Market: Report Scope

The latest publication by Persistence Market Research on the global intracranial therapeutic delivery market evaluates the opportunities and current market landscape and provides detailed analysis and updates about corresponding sections affecting the market. The study offers detailed insights into current market dynamics, which include the drivers, restraints, trends, and opportunities in the market. The principal aim of the market study is to present exclusive information about how the market will perform during the forecast period of 2022-2032.

Important indicators for the successful growth of the market are presented in this comprehensive report, which includes a Year-on-Year (Y-o-Y) growth analysis of the market, and compounded annual growth rate (CAGR), which are described exhaustively in Persistence Market Research's study. This research study can support readers to know the demand for intracranial therapeutic delivery therapies and the quantitative development opportunities during the study period.

The research is beneficial for shareholders in the landscape, including investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in the intracranial therapeutic delivery market. Insights and information presented in this Persistence Market Research study can be leveraged by shareholders in the intracranial therapeutic delivery market, industry experts, investors, researchers, and reporters, as well as business enthusiasts.

Market statistics, as well as information linked to the macro- as well as micro-economic variables affecting the business scenario in the intracranial therapeutic delivery market, are also included in the current study. Depending on potential developments in the market, substantive insights are also encountered in this report. Additionally, by the data submitted in this report, minor companies and new entrants in the industry can be aided in making suitable company choices to achieve traction in the market.

Key Market Segments

Persistence Market Research’s study on the intracranial therapeutic delivery market offers information divided into three important segments – therapy, indication, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

Therapy

  • Cell Therapy
  • Gene Therapy
  • Enzyme Replacement Therapy

Indication

  • Microbial Cell Culture
  • Mammalian Cell Culture
  • Plant Tissue Culture
  • Yeast Culture

Region

  • U.S.
  • Europe
  • ROW

Key Questions Answered in Report

  • Which regions will continue to remain the most profitable markets for intracranial therapeutic delivery over the coming years?
  • How will changing trends impact market growth?
  • How has the COVID-19 crisis impacted market growth?
  • How can market players capture the low-hanging opportunities in developed regions?
  • What are the strategies of stakeholders in the market to shape their position in this landscape?
  • What are the restraining factors that investors need to be aware of and might tackle while investing in the market?
  • What are the developmental trends that will impact the market?
  • How can companies in the intracranial therapeutic delivery market avail themselves of the growth opportunities in developed and emerging sectors?

Research Methodology

In Persistence Market Research’s study, a unique research methodology is utilized to conduct extensive research on the growth of the intracranial therapeutic delivery market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts to ensure the accuracy and reliability of the conclusions.

Secondary resources referred to by analysts during the production of the market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary and secondary resources acts as validation from companies in the market and makes Persistence Market Research’s projections on the growth prospects of the intracranial therapeutic delivery market more accurate and reliable.

Recommendations

Dearomatic Solvents Market

The global de-aromatic solvents market is estimated to expand at a CAGR of more than 6% over the forecast period of 2021-2031..

Propylene Glycol Ether Market

The global propylene glycol ether market is estimated to have been valued at US$ 1,604.1 Mn by 2017 end and is expected to reach US$ 2,088.4 Mn by the end of 2026 while expanding at a CAGR of 3.0% over the forecast period. .

Polyester Polyols Market

Polyester Polyols Market was valued at US$ 7,788.7 Mn in 2017 and is projected to rise to a valuation of US$ 11,963.6 Mn by the end of 2025..

Asia Pacific North America Europe Fluorinated Solvents Market

The Asia Pacific Fluorinated Solvents market is expected to register a CAGR of 9.0% over the forecast period (2018–2026)..

Our Clients

Our Clients